In 2008, Professor John Mitrofanis demonstrated the beneficial effects of red and near-infrared light on the brain, inspiring the Fonds Clinatec to explore its therapeutic potential. This technology, which works by stimulating the mitochondria of cells using light between 600 and 1300 nanometres, improves the production of ATP, thereby boosting the resistance of diseased cells.
Today, the Fonds Clinatec is developing a clinically tested near-infrared LED device capable of improving connections between brain cells. This safe, non-invasive treatment aims to restore neuronal function, for example after a stroke, by stimulating blood flow to aid recovery..
The research centre continues to explore this approach to treating neurodegenerative diseases such as Parkinson’s, Alzheimer’s and other related disorders, as well as sleep disorders, head injuries and cardiovascular disease, opening up new perspectives for modern medicine.
This work is being carried out with the support of the Covéa Mutual Group Foundation (MAAF, MMA and GMF).
